There are 128 resources available
The HTA perspective: Is tissue-independent approval the next top model?
Presenter: Sonia Garcia Perez
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
Implementation of NGS diagnostics in the NHS: The example of Belgium
Presenter: Marc Van Den Bulcke
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
cfDNA in CNS tumours
Presenter: Joan Seoane
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Slides
Webcast
Cell-free DNA methylomes and early-stage cancers
Presenter: Daniel De Carvalho
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Slides
Webcast
High-sensitivity ctDNA assays to detect low-burden disease
Presenter: Nitzan Rosenfeld
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Slides
Webcast
Leveraging mutational signatures for mutational calling in cell-free tumour DNA
Presenter: Dan Landau
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Christophe Massard
Session: Applications of artificial intelligence (AI) in oncology drug development
Resources:
Webcast
Q&A and live discussion
Presenter: Rebecca Dent
Session: Recent updates in treatment strategies
Resources:
Webcast
Q&A and live discussion
Presenter: Rolf Bjerkvig
Session: Blood-brain barrier
Resources:
Webcast
Artificial intelligence in cancer imaging: Clinical challenges and applications
Presenter: Eric Deutsch
Session: Applications of artificial intelligence (AI) in oncology drug development
Resources:
Slides
Webcast